Iron overload in myelodysplastic syndromes (MDS). - Wikidata - wikimedia - TriplyDB

Iron overload in myelodysplastic syndromes (MDS).

Iron overload in myelodysplastic syndromes (MDS).

http://www.wikidata.org/entity/Q47410460

about

Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice

P2860

Q58793901-9A37CFB7-D26F-4C58-9FE9-3CEFE1E60EF7

P2860

Iron overload in myelodysplastic syndromes (MDS).

http://www.wikidata.org/entity/Q47410460

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Iron overload in myelodysplastic syndromes (MDS).

@en

Iron overload in myelodysplastic syndromes

@nl

type

label

Iron overload in myelodysplastic syndromes (MDS).

@en

Iron overload in myelodysplastic syndromes

@nl

prefLabel

Iron overload in myelodysplastic syndromes (MDS).

@en

Iron overload in myelodysplastic syndromes

@nl

P1433

Q47410460-5631C4D4-9145-4925-91C2-019855E992CB

P1476

Q47410460-6B1B7ECF-706B-4C8C-BBE8-895FC0F2A532

P2860

Q47410460-1A500761-4DCB-4576-94BB-0660877CF2DB

Q47410460-1DCD5053-B3C2-43D6-985E-7EE5E218C24D

Q47410460-28B2B239-1023-43BC-A6C2-477A5187604F

Q47410460-2C376CA2-CC88-4756-8292-FF58B3F93B95

Q47410460-2DC12352-19B8-4E5C-B65C-C2110B907C3C

Q47410460-323F9E38-D860-49AB-AE44-16395C291FB2

Q47410460-38341F22-09E3-458A-AEFF-42B2125A8A3A

Q47410460-3EDAFD59-4826-402F-B0E9-B9ABE23BBE44

Q47410460-3F920B34-DC2F-489B-B50F-C2A3BA0B34B5

Q47410460-4822A20A-04D6-45B7-965B-36700ACE0DEF

P2888

Q47410460-C6FAE07C-9DBA-4759-9DF9-EC12D75DFDF9

P304

Q47410460-343E0198-02CD-4EB3-8752-5678208F16EF

P31

Q47410460-FFC02E72-FD09-498A-ADFB-B909E66DC57F

P356

Q47410460-3A10D820-0E0F-40FC-A9D6-EA754DF98927

P433

Q47410460-C72117C2-9D90-4F8C-A8AD-76FC75A63474

P478

Q47410460-F1CAA3BB-8026-4C60-BC5C-1F6A2C741D3B

P50

Q47410460-75BCA4D3-5F63-42C0-863B-B42681F964BE

P577

Q47410460-0C18E2C7-0934-40FE-AF64-26F734A85003

P698

Q47410460-BCFBD34B-5CA1-4453-BFAB-84F0267FD045

P356

S12185-017-2367-1

P1433

International Journal of Hematology

P1476

Iron overload in myelodysplastic syndromes (MDS).

@en

P2860

Atherogenesis and iron: from epidemiology to cellular level.

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis.

Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Hepcidin levels and their determinants in different types of myelodysplastic syndromes.

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

Effects of iron overload on the bone marrow microenvironment in mice

On T2* magnetic resonance and cardiac iron

Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes.

Enhanced growth of myelodysplastic colonies in hypoxic conditions

P2888

s12185-017-2367-1

P304

55-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-017-2367-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Norbert Gattermann

P577

2017-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29177643

http://www.w3.org/2001/XMLSchema#string